Patents by Inventor Tanja Rothammer-Hampl

Tanja Rothammer-Hampl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of a chemotherapeutic agent and an inhibitor of the TGF-beta system
    Patent number: 8476246
    Abstract: Pharmaceutical composition comprising a chemotherapeutic agent and a TGF-beta antisense oligonucleotide, wherein the antisense oligonucleotide reduces the sensitivity and IC50, respectively, of the cytotoxicity of the chemotherapeutic agent. Preferably, the antisense oligonucleotide is a TGF-beta 1, 2, and/or 3 antisense oligonucleotide and the chemotherapeutic agent is preferably gemcitabine, 5-fluorouracil, temozolomide, dacarbacine, docetaxel, cisplatin, oxaliplatin, tamoxifen, or irinotecan.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: July 2, 2013
    Assignee: Antisense Pharma GmbH
    Inventors: Karl-Hermann Schlingensiepen, Frank Jaschinski, Tanja Rothammer-Hampl, Anneliese Schneider
  • COMBINATION OF A CHEMOTHERAPEUTIC AGENT AND AN INHIBITOR OF THE TGF-BETA SYSTEM
    Publication number: 20120027873
    Abstract: Pharmaceutical composition comprising a chemotherapeutic agent and a TGF-beta antisense oligonucleotide, wherein the antisense oligonucleotide reduces the sensitivity and IC50, respectively, of the cytotoxicity of the chemotherapeutic agent. Preferably, the antisense oligonucleotide is a TGF-beta 1, 2, and/or 3 antisense oligonucleotide and the chemotherapeutic agent is preferably gemcitabine, 5-fluorouracil, temozolomide, dacarbacine, docetaxel, cisplatin, oxaliplatin, tamoxifen, or irinotecan.
    Type: Application
    Filed: July 30, 2010
    Publication date: February 2, 2012
    Applicant: ANTISENSE PHARMA GMBH
    Inventors: Karl-Hermann Schlingensiepen, Frank Jaschinski, Tanja Rothammer-Hampl, Anneliese Schneider